Clinical Trial Update: European Low and Intermediate Risk Neuroblastoma Protocol [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for European protocol addressing low and intermediate risk pediatric neuroblastoma and neonatal suprarenal masses; status complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Snippet

Sponsor: Instituto de Investigacion Sanitaria La Fe | Conditions: LOW AND INTERMEDIATE PAEDIATRIC NEUROBLASTOMA AND NEONATAL SUPRARENAL MASSES | Phase 3 | Status: COMPLETED